M&A Deal Summary

Express Scripts Holding Acquires Diversified Pharmaceutical Services

On February 9, 1999, Express Scripts Holding acquired healthcare services company Diversified Pharmaceutical Services from GlaxoSmithKline for 700M USD

Acquisition Highlights
  • This is Express Scripts Holding’s 2nd transaction in the Healthcare Services sector.
  • This is Express Scripts Holding’s 4th largest (disclosed) transaction.
  • This is Express Scripts Holding’s 2nd transaction in the United States.
  • This is Express Scripts Holding’s 1st transaction in Montana.

M&A Deal Summary
Date 1999-02-09
Target Diversified Pharmaceutical Services
Sector Healthcare Services
Buyer(s) Express Scripts Holding
Sellers(s) GlaxoSmithKline
Deal Type Divestiture
Deal Value 700M USD

Target

Diversified Pharmaceutical Services

St. Louis, Montana, United States
Diversified Pharmaceutical Services, Inc.is a provider of pharmaceutical benefit management services.

Search 192,907 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Express Scripts Holding

St. Louis, Missouri, United States

website

Category Company
Founded 1986
Sector Healthcare Services
Employees25,900
Revenue 100.1B USD (2017)
DESCRIPTION

Express Scripts Holding Co. is a provider of integrated pharmacy-benefit management services. Services include network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. Express Scripts Holding Co. was formed in 1986 and is based in St. Louis, Missouri.

DEAL STATS #
Overall 2 of 15
Sector (Healthcare Services) 2 of 9
Type (Divestiture) 2 of 4
State (Montana) 1 of 1
Country (United States) 2 of 15
Year (1999) 1 of 1
Size (of disclosed) 4 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
1998-04-01 ValueRx

United States

ValueRx provides healthcare services.

Buy $445M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2001-06-12 IVTx

St. Louis, Missouri, United States

IVTx, Inc. is a provider of infusion services in the Baltimore, Newark, Dallas, Houston, Philadelphia, and St. Louis areas.

Sell -

Seller(S) 1

SELLER

GlaxoSmithKline

Brentford, United Kingdom

website

Category Company
Founded 1715
Sector Life Science
Employees94,066
Revenue 34.1B GBP (2020)
DESCRIPTION
Entrance to a GlaxoSmithKline facility in Morristown, New Jersey.
Entrance to a GlaxoSmithKline facility in Morristown, New Jersey.

GlaxoSmithKline is a multinational pharmaceutical, biologics, vaccines and consumer healthcare company. GlaxoSmithKline was founded in 1715 and is based in Brentford, the United Kingdom.

DEAL STATS #
Overall 1 of 24
Sector (Healthcare Services) 1 of 3
Type (Divestiture) 1 of 23
State (Montana) 1 of 1
Country (United States) 1 of 4
Year (1999) 1 of 1
Size (of disclosed) 4 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
1995-01-26 Affymax

Cupertino, California, United States

Affymax is a biopharmaceutical company focused on anemia in kidney disease and cancer. Affymax was established in 2001 and is based in Cupertino, California.

Buy $533M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2000-01-17 SmithKline Beecham

Brentford, United Kingdom

SmithKline Beecham is a global pharmaceutical company based in Brentford, England.

Buy $75.7B
Mergr

Product

Company

Legal